autologous blood stem cells

Cell therapyexperimental

Clinical trial activity

3 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Jul 1, 2007 (NCT00530179)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetSupplementation

    supplementation

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • autologous blood stem cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01832428Phase 1/Phase 2 (Phase 2)Sep 30, 2014Chaitanya Hospital
NCT01648491N/AOct 1, 2011United States Army
NCT00530179N/AJul 1, 2007Roche, University of Calgary
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Chaitanya HospitalAcademic/Hospital1112014
RocheFor profit1012007
United States ArmyGovernment1112011
University of CalgaryAcademic/Hospital1112007
4 organizations
Page 1 / 1